Chaouat A, Weitzenblum E, Krieger J, Sforza E, Hammad H, Oswald M, Kessler R
Dept of Respiratory Medicine, University Hospital, Strasbourg, France.
Eur Respir J. 1999 May;13(5):1091-6. doi: 10.1034/j.1399-3003.1999.13e25.x.
The aim of the present study was to determine survival rates of obstructive sleep apnoea patients treated with continuous positive airway pressure (CPAP) and to investigate the prognostic value of pretreatment lung function and pulmonary haemodynamics. Two hundred and ninety-six patients, exhibiting > or = 20 apnoeas plus hypopnoeas per hour of sleep, were included. Patients were treated with nasal CPAP and regularly followed up. The cumulative survival rates were 0.96 (95% confidence interval (CI): 0.94-0.99) at 3 yrs and 0.93 (95% CI: 0.91-0.97) at 5 yrs. Most patients died from cardiovascular disease. Apart from age, covariates associated with a lower survival were the presence of a heavy smoking history, a low vital capacity, a low forced expiratory volume in one second (FEV1) and a high mean pulmonary artery pressure. Only three covariates were included by forward stepwise selection in the multivariate analysis, smoking habit (>30 pack-yrs), age and FEV1. The observed survival rates of the group as a whole were similar to those of the general population matched in terms of age, sex and smoking habit, except for patients between 50 and 60 yrs old who had reduced survival. This difference disappeared when patients of the present study with an associated chronic obstructive pulmonary disease were excluded from the comparison. In conclusion, survival of obstructive sleep apnoea patients treated with nasal continuous positive airway pressure is near to that of the general population. The prognosis is worse in subgroups of patients with a history of heavy smoking and with an associated chronic obstructive pulmonary disease.
本研究的目的是确定接受持续气道正压通气(CPAP)治疗的阻塞性睡眠呼吸暂停患者的生存率,并探讨治疗前肺功能和肺血流动力学的预后价值。纳入了296例每小时睡眠中呼吸暂停加呼吸浅慢次数≥20次的患者。患者接受经鼻CPAP治疗并定期随访。3年时的累积生存率为0.96(95%置信区间(CI):0.94 - 0.99),5年时为0.93(95%CI:0.91 - 0.97)。大多数患者死于心血管疾病。除年龄外,与较低生存率相关的协变量包括有重度吸烟史、肺活量低、一秒用力呼气容积(FEV1)低和平均肺动脉压高。多变量分析中通过向前逐步选择仅纳入了三个协变量,即吸烟习惯(>30包年)、年龄和FEV1。总体而言,该组观察到的生存率与在年龄、性别和吸烟习惯方面匹配的普通人群相似,但50至60岁的患者生存率降低。当本研究中伴有慢性阻塞性肺疾病的患者被排除在比较之外时,这种差异消失。总之,经鼻持续气道正压通气治疗的阻塞性睡眠呼吸暂停患者的生存率接近普通人群。有重度吸烟史和伴有慢性阻塞性肺疾病的患者亚组预后较差。